John Yates

2.4k total citations
14 papers, 1.8k citations indexed

About

John Yates is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, John Yates has authored 14 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Orthopedics and Sports Medicine, 9 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in John Yates's work include Bone health and osteoporosis research (14 papers), Bone health and treatments (9 papers) and Bone and Joint Diseases (6 papers). John Yates is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone health and treatments (9 papers) and Bone and Joint Diseases (6 papers). John Yates collaborates with scholars based in United States, Japan and Denmark. John Yates's co-authors include Arthur C. Santora, Pascale Chavassieux, Pierre J. Meunier, Georges Boivin, Peter Fratzl, Gideon A. Rodan, K. Klaushofer, Paul Roschger, S Rinnerthaler and Philip D. Ross and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of the American Geriatrics Society and Obstetrics and Gynecology.

In The Last Decade

John Yates

14 papers receiving 1.7k citations

Peers

Countries citing papers authored by John Yates

Since Specialization

Citations

This map shows the geographic impact of John Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Yates more than expected).

Fields of papers citing papers by John Yates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Yates. The network helps show where John Yates may publish in the future.

Co-authorship network of co-authors of John Yates

This figure shows the co-authorship network connecting the top 25 collaborators of John Yates. A scholar is included among the top collaborators of John Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Yates. John Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A meta-analysis characterizing the dose–response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women 2012 ·Osteoporosis International ·John Yates	14
2	Rapid Loss of Hip Fracture Protection After Estrogen Cessation: Evidence From the National Osteoporosis Risk Assessment 2004 ·Obstetrics and Gynecology ·John Yates, Elizabeth Barrett‐Connor, Suna Barlas, Ya-Ting Chen, Paul D. Miller, Ethel S. Siris	63
3	Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Michael R. McClung, Richard D. Wasnich, David Hosking, Claus Christiansen, Pernille Ravn, Mei Wu, (unknown), John Yates, Philip D. Ross, Arthur C. Santora, (unknown)	62
4	Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study 2002 ·Mayo Clinic Proceedings ·Susan L. Greenspan, (unknown), Richard P. Tonino, Mary E. Smith, Richard A. Petruschke, Lixia Wang, John Yates, Anne E. de Papp, Joanne Palmisano	70
5	Alendronate Reduces the Risk of Multiple Symptomatic Fractures: Results from the Fracture Intervention Trial 2002 ·Journal of the American Geriatrics Society ·Silvina Levis, Sara A. Quandt, Desmond Thompson, Jean C. Scott, Diane L. Schneider, Philip D. Ross, Dennis M. Black, Shailaja Suryawanshi, Marc C. Hochberg, John Yates	45
6	Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women 2001 ·Bone ·Paul Roschger, S Rinnerthaler, John Yates, Gideon A. Rodan, Peter Fratzl, K. Klaushofer	298
7	Relation Between Body Composition and Biochemical Markers of Bone Turnover Among Early Postmenopausal Women 2000 ·Journal of Clinical Densitometry ·(unknown), James W. Davis, (unknown), John Yates, Richard D. Wasnich, Pernille Ravn, Michael R. McClung, David Hosking	6
8	Weekly administration of alendronate: Rationale and plan for clinical assessment 2000 ·Clinical Therapeutics ·Henry G. Bone, S. Adámi, René Rizzoli, Murray J. Favus, Philip D. Ross, Arthur C. Santora, S. Prahalada, Anastasia G. Daifotis, John J. Orloff, John Yates	77
9	Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms 2000 ·Clinical Therapeutics ·Paul D. Miller, Grattan C. Woodson, Angelo A. Licata, Mark P. Ettinger, (unknown), Mary E. Smith, Lixia Wang, John Yates, Mary E. Melton, Joanne Palmisano	43
10	Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women 2000 ·Bone ·Georges Boivin, Pascale Chavassieux, Arthur C. Santora, John Yates, Pierre J. Meunier	456
11	Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. 2000 ·PubMed ·Thomas J. Schnitzer, Henry G. Bone, G Crepaldi, S. Adámi, Michael R. McClung, (unknown), Dieter Felsenberg, R. R. Recker, (unknown), C. Roux, A Pinchera, A. Joseph Foldes, S. L. Greenspan, Michael A. Levine, Ronald Emkey, Arthur C. Santora, Amandeep Kaur, Desmond Thompson, John Yates, John J. Orloff	235
12	Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis 2000 ·Aging Clinical and Experimental Research ·(unknown), Thomas J. Schnitzer, Henry G. Bone, Gaetano Crepaldi, S. Adámi, Michael R. McClung, Douglas P. Kiel, Dieter Felsenberg, Robert R. Recker, Richard P. Tonino, C. Roux, A Pinchera, A. Joseph Foldes, S. L. Greenspan, Michael A. Levine, Ronald Emkey, A. Santora, Amandeep Kaur, Desmond Thompson, John Yates, John J. Orloff	300
13	Bone turnover rate does not predict BMD response to alendronate 1996 ·Osteoporosis International ·Laurence Hirsch, Arthur C. Santora, Uma Kher, John Yates, Nicole F. Bell, R Correa-Rotter	1
14	Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneus ultrasound 1995 ·Bone ·Philip D. Ross, Chia‐Chang Huang, James W. Davis, (unknown), John Yates, John M. Vogel, Richard D. Wasnich	159

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact